20th edition of BioAsia all set to be held in Hyderabad on February 24-26

New Delhi: BioAsia 2023, the annual flagship event of the Government of Telangana, will be held from February 24 to 26, 2023 in Hyderabad. The event is themed “Advancing for ONE: Shaping the next generation of humanized healthcare”.

The event has been a catalyst for 20 years in bringing together prominent dignitaries and delegates, leaders, entrepreneurs, and professionals from the life science and healthcare sector from around the world year on year.

According to Shakthi Nagappan, CEO, BioAsia and Director (Life Sciences), Government of Telangana, Bio Asia 2023 will bring together life sciences and healthcare leaders, academia, start-ups, regulators and investors, on one stage to deliberate on the cross-cutting themes of One Health, disruptive technologies in health, and accessibility and affordability in healthcare for all.

BioVoice News is one of the leading media partners of BioAsia 2023.

The event will also have a start-up showcase where over 100 select health-tech entrepreneurs from across the world can pitch their innovative solutions to pressing health issues, he added.

BioAsia 2023 has partnered with the Department of Micro Small and Medium Enterprises (MSME) to promote the MSME sector in the upcoming 20th edition of BioAsia – Asia’s largest life-sciences and health tech forum and the annual flagship event of the Government of Telangana.

A dedicated MSME Pavilion has been proposed to be installed in the tradeshow with around 60 companies from the MSME sector covering Medical Devices, Pharmaceuticals, and allied industries. Through the Procurement & Market Support (PMS) – Market Access Initiatives of Di-MSME, the cost of participation for MSMEs are being subsidized upto 100%.

In this context, Dr Chandra Sekhar, Additional Development Commissioner, MSME-DI, Hyderabad said, “The 20th celebratory edition of BioAsia 2023, with the theme Advancing for ONE: Shaping the next generation of humanised healthcare, is also expected to advance the growth opportunities for MSME units in India and benefit from its driving investments and global opportunities into the life sciences. With this collaboration and participation in BioAsia 2023, we trust the MSME players will be immensely benefitted from its gained significant stature in healthcare industries across the globe.”

Over the years, the event has immensely benefitted from its participant history including the likes of several Nobel Prize winners, Lasker Awardees and eminent industry leaders like Mr. Bill Gates (Chair, Gates Foundation), Mr. Satya Nadella (CEO of Microsoft), Mr. Alex Gorsky (Executive Chairman, Johnson & Johnson), Dr. Vas Narasimhan (CEO, Novartis), Mr. Geoff Martha (Chairman & CEO, Medtronic), besides hosting the Country Ministers and Delegates from Asia, America, Africa, and Europe. Despite being a hybrid event last year, BioAsia 2022 was extremely successful with the virtual participation of about 37,500 delegates from about 70 Countries.